Baicalein inhibits MMP-2 expression in human ovarian cancer cells by suppressing the p38 MAPK-dependent NF-κB signaling pathway

Anti-Cancer Drugs

Volumn 26, Issue 6, 2015, Pages 649-656

  Yan, Hao ^a   Xin, Shaobin ^b   Wang, Hui ^a   Ma, Jing ^a   Zhang, Heng ^a   Wei, Hailing ^b  

^a Department of Oncology ^*  (China)

^b TIANJIN UNION MEDICAL CENTER   (China)

Author keywords

baicalein; invasion; MMP 2; nuclear factor B; ovarian cancer cells; p38

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTINEOPLASTIC AGENT; BAICALEIN; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRROLIDINE DITHIOCARBAMATE; FLAVANONE DERIVATIVE;

ARTICLE; DOSE RESPONSE; DRUG PROTEIN BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OVARIAN CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; FEMALE; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FEMALE; FLAVANONES; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NF-KAPPA B; OVARIAN NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84930636056     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0000000000000230     Document Type: Article

References (46)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30.
2. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol 2010; 177:1053-1064.
3. Hua H, Li M, Luo T, Yin Y, Jiang Y. Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci 2011; 68:3853-3868.
4. Fishman D, Bafetti L, Stack M. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis 1995; 16:150-159.
5. Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, et al. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 2004; 190:899-909.
6. Perigny M, Bairati I, Harvey I, Beauchemin M, Harel F, Plante M, et al. Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Am J Pathol 2008; 129:226-231.
7. Kenny HA, Lengyel E. MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle 2009; 8:683-688.
8. Li C, Lin G, Zuo Z. Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos 2011; 32:427-445.
9. Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004; 96:229-245.
10. Lu Y, Joerger R, Wu C. Study of the chemical composition and antimicrobial activities of ethanolic extracts from roots of Scutellaria baicalensis Georgi. J Agric Food Chem 2011; 59:10934-10942.
11. Shieh D-e, Liu L-T, Lin C-C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 1999; 20:2861-2865.
12. Ikezoe T, Chen SS, Heber D, Taguchi H, Koeffler HP. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest. Prostate 2001; 49: 285-292.
13. Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K, et al. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 2000; 55:951-955.
14. Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, et al. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 2000; 148:19-25.
15. Himeji M, Ohtsuki T, Fukazawa H, Tanaka M, Yazaki S-i, Ui S, et al. Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell. Cancer Lett 2007; 245:269-274.
16. Kilani RT, Tamimi Y, Karmali S, Mackey J, Hanel EG, Wong KK, et al. Selective cytotoxicity of gemcitabine in bladder cancer cell lines. Anticancer Drugs 2002; 13:557-566.
17. Cannistra SA. Cancer of the ovary. N Engl J Med 2004; 351:2519-2529.
18. Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat Rev 2009; 35:57-68.
19. Stack MS, Ellerbroek SM, Fishman DA. The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. Int J Oncol 1998; 12:569-576.
20. Roomi MW, Kalinovsky T, Rath M, Niedzwiecki A. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines. Oncol Rep 2012; 28:768-776.
21. Zhang Z, Lv J, Lei X, Li S, Zhang Y, Meng L, et al. Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway. PLoS One 2014; 9:e90318.
22. Kenny HA, Kaur S, Coussens LM, Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008; 118:1367-1379.
23. Wang L, Ling Y, Chen Y, Li C-L, Feng F, You Q-D, et al. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett 2010; 297:42-48.
24. Chandrashekar N, Selvamani A, Subramanian R, Pandi A, Thiruvengadam D. Baicalein inhibits pulmonary carcinogenesis-associated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in-vivo. Toxicol Appl Pharmacol 2012; 261:10-21.
25. Chen K, Zhang S, Ji Y, Li J, An P, Ren H, et al. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via downregulation of the ERK pathway. PLoS One 2013; 8:e72927.
26. Prasad S, Ravindran J, Aggarwal BB. NF-κB and cancer: how intimate is this relationship. Mol Cell Biochem 2010; 336:25-37.
27. Li J, Jia H, Xie L, Wang X, He H, Lin Y, et al. Association of constitutive nuclear factor-κB activation with aggressive aspects and poor prognosis in cervical cancer. Int J Gynecol Cancer 2009; 19:1421-1426.
28. Tran NL, McDonough WS, Savitch BA, Fortin SP, Winkles JA, Symons M, et al. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome. Cancer Res 2006; 66:9535-9542.
29. Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, et al. Association of activated transcription factor nuclear factor κB with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 2006; 24:748-754.
30. Majdalawieh A, Ro HS. Regulation of I-Ba function and NF-κB signaling: AEBP1 is a novel proinflammatory mediator in macrophages. Mediators Inflamm 2010; 2010: 823821.
31. Kiriakidis S, Andreakos E, Monaco C, Foxwell B, Feldmann M, Paleolog E. VEGF expression in human macrophages is NF-κB-dependent: studies using adenoviruses expressing the endogenous NF-κB inhibitor I-Ba and a kinasedefective form of the I-B kinase 2. J Cell Sci 2003; 116:665-674.
32. Surh Y-J, Chun K-S, Cha H-H, Han SS, Keum Y-S, Park K-K, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 2001; 480:243-268.
33. Lee SJ, Seo KW, Yun MR, Bae SS, Lee WS, Hong KW, et al. 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-κB signaling pathways. Free Radic Bio Med 2008; 45:1487-1492.
34. Hsieh CJ, Hall K, Ha T, Li C, Krishnaswamy G, Chi DS. Baicalein inhibits IL-1β-and TNF-a-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway. Clin Mol Allergy 2007; 5:5.
35. Peng C-Y, Pan S-L, Huang Y-W, Guh J-H, Chang Y-L, Teng C-M. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-κB activity in vascular smooth-muscle cells. Naunyn Schmiedebergs Arch Pharmacol 2008; 378:579-588.
36. Kang BY, Chung SW, Kim SH, Cho D, Kim TS. Involvement of nuclear factor-κB in the inhibition of interleukin-12 production from mouse macrophages by baicalein, a flavonoid in Scutellaria baicalensis. Planta Med 2003; 69:687-691.
37. del Barco Barrantes I, Nebreda AR. Roles of p38 MAPKs in invasion and metastasis. Biochem Soc Trans 2012; 40:79-84.
38. Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB, et al. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 2010; 70:832-841.
39. Kim E, Kim M, Moon A. TGF-β-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 2004; 25:1375-1382.
40. Park C-M, Park M-J, Kwak H-J, Lee H-C, Kim M-S, Lee S-H, et al. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 2006; 66:8511-8519.
41. Shuto T, Xu H, Wang B, Han J, Kai H, Gu XX, et al. Activation of NF-κ B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK a/β-IBa and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci U S A 2001; 98:8774-8779.
42. Chou RH, Hsieh SC, Yu YL, Huang MH, Huang YC, Hsieh YH. Fisetin inhibits migration and invasion of human cervical cancer cells by downregulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway. PLoS One 2013; 8: e71983.
43. Jijon H, Allard B, Jobin C. NF-κB inducing kinase activates NF-κB transcriptional activity independently of I-B kinase through a p38 MAPKdependent RelA phosphorylation pathway. Cell Signal 2004; 16:1023-1032.
44. Saccani S, Pantano S, Natoli G. p38-dependent marking of inflammatory genes for increased NF-κB recruitment. Nat Immunol 2001; 3:69-75.
45. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, et al. p38 MAPK and NF-κ B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 2000; 275:23814-23824.
46. Kim SD, Lee YJ, Baik JS, Han JY, Lee CG, Hoe K, et al. Baicalein inhibits agonist-and tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation. Biochem Pharmacol 2014; 92:251-265.